1. Home
  2. LKFN vs NVAX Comparison

LKFN vs NVAX Comparison

Compare LKFN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LKFN
  • NVAX
  • Stock Information
  • Founded
  • LKFN 1872
  • NVAX 1987
  • Country
  • LKFN United States
  • NVAX United States
  • Employees
  • LKFN N/A
  • NVAX N/A
  • Industry
  • LKFN Major Banks
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LKFN Finance
  • NVAX Health Care
  • Exchange
  • LKFN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • LKFN 1.7B
  • NVAX 1.3B
  • IPO Year
  • LKFN 1997
  • NVAX 1995
  • Fundamental
  • Price
  • LKFN $59.73
  • NVAX $8.10
  • Analyst Decision
  • LKFN Buy
  • NVAX Hold
  • Analyst Count
  • LKFN 2
  • NVAX 5
  • Target Price
  • LKFN $68.00
  • NVAX $9.80
  • AVG Volume (30 Days)
  • LKFN 94.6K
  • NVAX 4.6M
  • Earning Date
  • LKFN 10-27-2025
  • NVAX 11-11-2025
  • Dividend Yield
  • LKFN 3.34%
  • NVAX N/A
  • EPS Growth
  • LKFN N/A
  • NVAX N/A
  • EPS
  • LKFN 3.67
  • NVAX 2.54
  • Revenue
  • LKFN $239,375,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • LKFN $16.89
  • NVAX $60.81
  • Revenue Next Year
  • LKFN $4.98
  • NVAX N/A
  • P/E Ratio
  • LKFN $16.31
  • NVAX $3.18
  • Revenue Growth
  • LKFN N/A
  • NVAX 9.22
  • 52 Week Low
  • LKFN $50.00
  • NVAX $5.01
  • 52 Week High
  • LKFN $78.61
  • NVAX $11.55
  • Technical
  • Relative Strength Index (RSI)
  • LKFN 37.27
  • NVAX 42.78
  • Support Level
  • LKFN $61.07
  • NVAX $8.24
  • Resistance Level
  • LKFN $64.10
  • NVAX $9.34
  • Average True Range (ATR)
  • LKFN 1.91
  • NVAX 0.52
  • MACD
  • LKFN -0.42
  • NVAX -0.11
  • Stochastic Oscillator
  • LKFN 23.47
  • NVAX 6.07

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: